Recently the Ministry of Ayush has launched a massive nationwide campaign to distribute its polyherbal ayurvedic drugs AYUSH 64 and Sidha drug Kabasura Kudineer for the benefit of COVID-19 patients that have not been hospitalised.
Daily Current Affairs Quiz 2021
The efficacy of these drugs has been proved through robust multi-centre clinical trials.
Kabasura Kudineer, a Siddha medicine was also subjected to clinical trials for studying the efficacy in Covid-19 patients by Central Council for Research in Siddha (CCRS) under Ministry of Ayush.
AYUSH-64 is recommended in National Clinical Management Protocol based on Ayurveda and Yoga which is vetted by National Task Force on COVID Management of ICMR and Guidelines for Ayurveda Practitioners for COVID-19 Patients in Home Isolation.
Kabasura Kudineer is included in Guidelines for Siddha Practitioners for COVID 19, Ministry of Ayush Govt. of India.
